Full Press Release Details
ADVISORY, Feb. 12, 2013 (GLOBE NEWSWIRE) --
Prothena [PRTA], a biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, will visit the NASDAQ MarketSite in Times Square.
In honor of the occasion, Dale Schenk, CEO will ring the Opening Bell.
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
Wednesday, February 13, 2013 - 9:15 a.m. to 9:30 a.m. ET
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
Facebook and Twitter:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.
For news tweets, please visit our Twitter page at: http://twitter.com/nasdaqomx.
A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx.
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Prothena Corporation plc [PRTA]:
Prothena Corporation plc (Nasdaq:PRTA) is a biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion, particularly on the discovery and development of potential therapeutic monoclonal antibodies directed specifically to disease-causing proteins. These potential therapies have a broad range of indications, including AL and AA forms of amyloidosis, Parkinson's disease and related synucleinopathies, and novel cell adhesion targets involved in autoimmune disease and metastatic cancers. For more information, please visit www.prothena.com.
About NASDAQ OMX Group: